April 13, 2017 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Gilead Sciences, Inc., a stock transaction, valued at $50,001 - $100,000. The trade took place on April 13, 2017 and was disclosed on January 24, 2017 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.